Table 3.
Enrolment into the intermittent preventive treatment intervention group in 2014, by round and treatment coverage
|
Enrolled (n=23 280) |
Received any dose of DP |
Received a full course of DP (three doses) |
||||
|---|---|---|---|---|---|---|
| Number (%) | Median (IQR) proportion per cluster (%) | Number (%) | Median (IQR) proportion per cluster (%) | Number (%) | Median (IQR) proportion per cluster (%) | |
| Round 1 (June 30–July 25) | 2680 (12%) | 13% (9–19) | 2680 (12%) | 13% (9–19) | 2210 (9%) | 11% (8–16) |
| Round 2 (July 28–Aug 22) | 3290 (14%) | 14% (9–20) | 3287 (14%) | 14% (9–20) | 2254 (10%) | 9% (6–15) |
| Round 3 (Aug 25–Sept 19) | 3601 (15%) | 15% (11–24) | 3601 (15%) | 15% (11–24) | 3032 (13%) | 13% (7–18) |
| Round 4 (Sept 22–Oct 17) | 8159 (35%) | 36% (29–49) | 8154 (35%) | 36% (29–49) | 6778 (29%) | 32% (24–40) |
| Round 5 (Oct 20–Nov 14) | 8634 (37%) | 41% (33–49) | 8628 (37%) | 41% (33–49) | 7007 (30%) | 33% (23–39) |
| Round 6 (Nov 17–Dec 12) | 6714 (29%) | 33% (22–41) | 6714 (29%) | 33% (22–41) | 5110 (22%) | 24% (15–33) |
23 280 indivuals were registered in the 42 intervention schools. DP=dihydroartemisinin-piperaquine.